Rapport
Hexahydrocannabinol (HHC) and related substances
Auteur(s) :
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction) ;
UJVARY, I. ;
EVANS-BROWN, M. ;
GALLEGOS, A. ;
PLANCHUELO, G. ;
DE MORAIS, J. ;
CHRISTIE, R. ;
JORGE, R. ;
SEDEFOV, R.
Année
2023
Page(s) :
107 p.
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : OEDT / EMCDDA
Collection :
Technical reports
ISBN :
978-92-9497-855-4
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus géographique
EUROPE
Thésaurus mots-clés
CANNABINOIDES
;
DROGUES DE SYNTHESE
;
CHIMIE
;
PHARMACOLOGIE
;
TOXICOLOGIE
;
PHARMACOCINETIQUE
;
MARCHE DE LA DROGUE
Résumé :
The markets for hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSC) are rapidly evolving areas with relatively limited information currently available. The European situation presented in Section 1 can only provide an overview and will necessarily be incomplete, it also serves to highlight the need for close monitoring. During 2023, a number of developments, such as reports of important law enforcement seizures and changes in legal status, have already taken place in some countries and, where possible, updates have been included.
Affiliation :
iKem BT, H-1033 Budapest, Hungary
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal
Autre(s) lien(s) :
Press release (17/04/2023)
Historique